Test systems to identify reproductive toxicants.
Experience with drugs and other xenobiotics indicates that both animal testing and epidemiological studies are necessary to provide adequate data for an estimation of risks that might be associated with exposure to a chemical substance. In this review, the pros and cons of test systems for reproductive toxicity are discussed. Usually, several studies are performed to cover the different phases of the reproductive cycle. In the preclinical development of drugs, the three so-called 'segment testing protocols' have been used for several decades now. More recently, new testing concepts have been accepted internationally which include more flexibility in implementation. Several examples of compounds with the potential for reproductive toxicity are presented in more detail in a discussion of some pitfalls of the tests for fertility (phthalates and fluoroquinolones), teratogenicity (acyclovir and protease inhibitors) and postnatal developmental toxicity (fluoroquinolones). In addition, important aspects of kinetics and metabolism as a prerequisite for a rational interpretation of results from toxicological studies are briefly discussed. In vitro assays are useful for supplementing the routinely used in vivo approaches or for studying an expected or defined effect, but they are not suitable for revealing an unknown effect of a chemical on the complex reproductive process.
Riecke
K
K
Institute for Clinical Pharmacology and Toxicology, Department of Toxicology, Benjamin Franklin Medical Center, Frie Universität Berlin, Germany.
Stahlmann
R
R
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D011247:Pregnancy; D012098:Reproduction / Q000187:drug effects*; D013723:Teratogens / Q000633:toxicity; D015262:Xenobiotics / Q000378:metabolism / Q000493:pharmacokinetics / Q000633:toxicity*
D013723:Teratogens; D015262:Xenobiotics